ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,554Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 81

$1.67M Total Retail Price of All Prescriptions

Rank: 7 out of 81

753 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 753 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

13% of this provider’s 753 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 27,872 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 33.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
FUROSEMIDE 1,126 1,059 1 1
LEVOTHYROXINE SODIUM 1,100 1,063 2 3
LISINOPRIL 934 884 3 2
OMEPRAZOLE 868 816 4 4
DONEPEZIL HCL 843 832 5 8
SIMVASTATIN 843 736 5 5
NAMENDA 843 819 5 11
CITALOPRAM HBR 648 589 8 10
METOPROLOL TARTRATE 617 592 9 7
TRAMADOL HCL 598 539 10 17
WARFARIN SODIUM 564 483 11 9
AMLODIPINE BESYLATE 501 461 12 6
HYDROCODONE-ACETAMINOPHEN 474 406 S3 13 12
POTASSIUM CHLORIDE 454 443 14 16
JANTOVEN 399 373 15 44
GABAPENTIN 396 318 16 13
MIRTAZAPINE 355 322 17 14
EXELON 332 332 18 47
RISPERIDONE 330 282 19 26
LANTUS 318 264 20 23
CARVEDILOL 314 301 21 27
BUSPIRONE HCL 308 263 22 117
TRAZODONE HCL 307 270 23 20
ESCITALOPRAM OXALATE 301 274 24 42
POLYETHYLENE GLYCOL 3350 294 286 25 35
MELOXICAM 272 248 26 68
DIVALPROEX SODIUM 262 208 27 25
ALENDRONATE SODIUM 241 237 28 32
CLOPIDOGREL 237 224 29 37
TAMSULOSIN HCL 235 216 30 29
DIGOXIN 219 216 31 49
METFORMIN HCL 213 195 32 15
HYDROCHLOROTHIAZIDE 211 180 33 21
SERTRALINE HCL 206 184 34 19
METOPROLOL SUCCINATE 204 192 35 22
IPRATROPIUM-ALBUTEROL 199 189 36 57
LOSARTAN POTASSIUM 195 172 37 34
CLONIDINE HCL 194 156 38 59
ATORVASTATIN CALCIUM 193 159 39 18
FENTANYL 192 169 S2 40 65
QUETIAPINE FUMARATE 186 170 41 31
LIDODERM 185 179 42 43
OXYBUTYNIN CHLORIDE ER 185 169 42 53
ATENOLOL 184 157 44 28
KLOR-CON M20 182 166 45 39
ISOSORBIDE MONONITRATE ER 182 159 45 38
PLAVIX 179 163 47 63
SULFAMETHOXAZOLE-TRIMETHOPRIM 179 169 47 77
CYMBALTA 177 163 49 30
LYRICA 175 96 50 75
CIPROFLOXACIN HCL 170 156 51 64
ROPINIROLE HCL 168 164 52 108
ALLOPURINOL 163 150 53 41
BYSTOLIC 153 152 54 129
DIOVAN 153 152 54 50
AZITHROMYCIN 152 137 56 84
CARBIDOPA-LEVODOPA 147 145 57 62
PRAVASTATIN SODIUM 146 146 58 33
LACTULOSE 146 105 58 80
NYSTOP 144 116 60 96
PREDNISONE 139 137 61 40
ALBUTEROL SULFATE 138 134 62 56
ABILIFY 131 108 63 105
NOVOLOG 131 117 63 51
NYSTATIN 127 114 65 90
VENLAFAXINE HCL ER 124 124 66 78
HYDRALAZINE HCL 123 100 67 52
PROMETHAZINE HCL 122 107 R 68 74
SINGULAIR 116 116 69 97
LATANOPROST 113 108 70 98
SPIRONOLACTONE 112 105 71 70
HYDROXYZINE HCL 109 94 R 72 193
CEPHALEXIN 108 100 73 73
OXYCODONE-ACETAMINOPHEN 104 95 S2 74 24
JANUVIA 102 87 75 100
CILOSTAZOL 99 95 76 249
METOLAZONE 99 74 76 166
FLUTICASONE PROPIONATE 99 96 76 58
DOXYCYCLINE HYCLATE 98 89 79 92
VENLAFAXINE HCL 98 94 79 175
LEVETIRACETAM 97 69 81 48
NITROFURANTOIN MONO-MACRO 97 93 81 87
GLIMEPIRIDE 95 86 83 89
GALANTAMINE HBR 95 84 83 162
KLOR-CON M10 94 86 85 94
ZOLPIDEM TARTRATE 94 73 85 45
ENABLEX 93 93 87 189
GLIPIZIDE 93 83 87 46
RANITIDINE HCL 92 88 89 61
MECLIZINE HCL 91 88 90 241
NEXIUM 87 84 91 66
DILTIAZEM HCL 87 86 91 222
AMIODARONE HCL 87 86 91 119
PANTOPRAZOLE SODIUM 85 71 94 72
LEXAPRO 85 79 94 110
CEFTRIAXONE 82 78 96 138
FINASTERIDE 80 80 97 93
LEVOFLOXACIN 78 71 98 121
MORPHINE SULFATE 77 76 S2 99 263
ADVAIR DISKUS 75 75 100 67
SEROQUEL 74 63 101 79
METOCLOPRAMIDE HCL 73 73 102 118
BACLOFEN 72 53 103 86
ENULOSE 70 62 104 107
CLOTRIMAZOLE-BETAMETHASONE 70 59 104 261
ACTOS 69 67 106 158
ONDANSETRON HCL 68 63 107 268
DOXAZOSIN MESYLATE 64 63 108 164
LIDOCAINE HCL 62 58 109 185
LANTUS SOLOSTAR 62 61 109 69
METHOCARBAMOL 59 51 R 111 220
CRESTOR 57 52 112 81
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 55 112 99
GENERLAC 56 49 114 103
NITROFURANTOIN 56 42 114 147
MONTELUKAST SODIUM 56 55 114 169
DILTIAZEM 24HR CD 54 54 117 83
KETOCONAZOLE 52 34 118 192
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 23, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.